
Contents
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Pulmonary Neoplasms Pulmonary Neoplasms
-
Solitary Pulmonary Nodule Solitary Pulmonary Nodule
-
Clinical Evaluation Clinical Evaluation
-
Diagnosis Diagnosis
-
Decision Making Decision Making
-
-
Lung Cancer Lung Cancer
-
Overall Survival Overall Survival
-
Cell Types Cell Types
-
Clinical Features Clinical Features
-
Squamous Cell Carcinoma Squamous Cell Carcinoma
-
Adenocarcinoma Adenocarcinoma
-
Bronchoalveolar Cell Carcinoma Bronchoalveolar Cell Carcinoma
-
Large Cell Carcinoma Large Cell Carcinoma
-
Small Cell Carcinoma Small Cell Carcinoma
-
Carcinoid Carcinoid
-
Bronchial Gland Tumors Bronchial Gland Tumors
-
Mesenchymal Tumors Mesenchymal Tumors
-
Lymphoma Lymphoma
-
Diagnostic Tests Diagnostic Tests
-
Paraneoplastic Syndromes Paraneoplastic Syndromes
-
Endocrine Endocrine
-
Nervous System Nervous System
-
Skeletal Skeletal
-
Others Others
-
-
-
Pulmonary Metastases Pulmonary Metastases
-
-
Vascular Diseases Vascular Diseases
-
Pulmonary Embolism Pulmonary Embolism
-
Etiology Etiology
-
Clinical Features Clinical Features
-
Diagnostic Tests Diagnostic Tests
-
Treatment Treatment
-
Inferior Vena Cava Interruption Inferior Vena Cava Interruption
-
Prophylaxis Prophylaxis
-
Complications of PE Complications of PE
-
-
Pulmonary Vasculitides Pulmonary Vasculitides
-
Wegener Granulomatosis Wegener Granulomatosis
-
Giant Cell (Temporal) Arteritis Giant Cell (Temporal) Arteritis
-
Churg-Strauss Syndrome Churg-Strauss Syndrome
-
Behçet Disease Behçet Disease
-
Takayasu Arteritis Takayasu Arteritis
-
Mixed Cryoglobulinemia Mixed Cryoglobulinemia
-
Polyarteritis Nodosa Polyarteritis Nodosa
-
Secondary Vasculitis Secondary Vasculitis
-
Alveolar Hemorrhage Syndromes Alveolar Hemorrhage Syndromes
-
Goodpasture Syndrome Goodpasture Syndrome
-
Glomerulonephritis Glomerulonephritis
-
Vasculitides Vasculitides
-
Microscopic Polyangiitis Microscopic Polyangiitis
-
Mitral Valve Disease Mitral Valve Disease
-
Idiopathic Pulmonary Hemosiderosis Idiopathic Pulmonary Hemosiderosis
-
Toxic Alveolar Hemorrhage Toxic Alveolar Hemorrhage
-
Pulmonary Arterial Hypertension Pulmonary Arterial Hypertension
-
-
-
-
-
-
-
-
-
-
-
Part III Neoplastic and Vascular Diseases
Get access-
Published:August 2010
Cite
Abstract
Neoplastic and vascular disorders are reviewed. Lung cancer is the most common malignancy and cause of cancer death in both men and women worldwide. The incidence of new lung cancers has continued to decrease in men and increase in women. The risk factors include cigarette smoking, other carcinogens, cocarcinogens, radon exposure, arsenic, asbestos, coal dust, chromium, vinyl chloride, chloromethyl ether, and chronic lung injury. Genetic and nutritional factors have been implicated. Among vascular disorders, pulmonary embolism is most common. Pulmonary embolism (PE) is the cause of death in 5% to 15% of hospitalized patients who die in the United States. In a multicenter study of PE, the mortality rate at 3 months was 15% and important prognostic factors included age older than 70 years, cancer, congestive heart failure, COPD, systolic arterial hypotension, tachypnea, and right ventricular hypokinesis.
Sign in
Personal account
- Sign in with email/username & password
- Get email alerts
- Save searches
- Purchase content
- Activate your purchase/trial code
- Add your ORCID iD
Purchase
Our books are available by subscription or purchase to libraries and institutions.
Purchasing informationMonth: | Total Views: |
---|---|
October 2022 | 1 |
May 2024 | 1 |
June 2024 | 1 |
Get help with access
Institutional access
Access to content on Oxford Academic is often provided through institutional subscriptions and purchases. If you are a member of an institution with an active account, you may be able to access content in one of the following ways:
IP based access
Typically, access is provided across an institutional network to a range of IP addresses. This authentication occurs automatically, and it is not possible to sign out of an IP authenticated account.
Sign in through your institution
Choose this option to get remote access when outside your institution. Shibboleth/Open Athens technology is used to provide single sign-on between your institution’s website and Oxford Academic.
If your institution is not listed or you cannot sign in to your institution’s website, please contact your librarian or administrator.
Sign in with a library card
Enter your library card number to sign in. If you cannot sign in, please contact your librarian.
Society Members
Society member access to a journal is achieved in one of the following ways:
Sign in through society site
Many societies offer single sign-on between the society website and Oxford Academic. If you see ‘Sign in through society site’ in the sign in pane within a journal:
If you do not have a society account or have forgotten your username or password, please contact your society.
Sign in using a personal account
Some societies use Oxford Academic personal accounts to provide access to their members. See below.
Personal account
A personal account can be used to get email alerts, save searches, purchase content, and activate subscriptions.
Some societies use Oxford Academic personal accounts to provide access to their members.
Viewing your signed in accounts
Click the account icon in the top right to:
Signed in but can't access content
Oxford Academic is home to a wide variety of products. The institutional subscription may not cover the content that you are trying to access. If you believe you should have access to that content, please contact your librarian.
Institutional account management
For librarians and administrators, your personal account also provides access to institutional account management. Here you will find options to view and activate subscriptions, manage institutional settings and access options, access usage statistics, and more.